News Focus
News Focus
icon url

DewDiligence

01/23/13 5:10 PM

#155762 RE: biomaven0 #155695

Levadex has peak annual sales potential of $500M, according to AGN’s CC today; all of this comes from the US and Canada. The addressable patient pool is about 10x that of Botox for chronic migraine.